Teva

Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a…

Alvotech (NASDAQ: ALVO) og Teva Pharmaceuticals, bandarískt dótturfélag Teva Pharmaceutical Industries Ltd. (NYSE og TASE: TEVA) tilkynntu í dag um aukið samstarf á sviði þróunar,…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) ended 2022 with revenue of $14.9 billion, in the lower range of the guidance provided in the final quarter. In…

© Reuters. The logo of Teva Pharmaceutical Industries is seen in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen (Reuters) -Israeli drugmaker Teva Pharmaceutical Industries…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported today that it has either already settled with or confirmed participation from 48 of the 50 US states…

The U.S. Food and Drug Administration’s (FDA) regulatory review is anticipated to be completed in the second half of 2023Stelara® (ustekinumab) is prescribed to treat a variety of…

Pune, Dec. 15, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global central nervous system treatment market is expected to clock US$ 191.01…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Kare Schultz will step down at the end of next month, sooner than expected. Teva today announced the…

AP NEW YORK (AP) — New York will receive up to $524 million from drugmaker Teva to settle claims that the company contributed to the U.S. opioid…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today reported results for the quarter ended September 30, 2022. Revenue for the second quarter was $3.6…